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Abstract 
Background: Distal coronary to aortic pressure ratio (Pd/Pa) and instantaneous 
wave-free ratio (iFR®) are indices of functional significance of a coronary 
stenosis measured without hyperemia. It has been suggested that iFR® has 
superior diagnostic accuracy to Pd/Pa when compared to Fractional Flow 
Reserve (FFR).  
Hypotheses: In comparison to FFR, revascularization decisions based on either 
binary cut-off values for iFR and Pd/Pa or hybrid strategies incorporating iFR® or 
Pd/Pa will result in similar levels of disagreement.  
Methods and Results: A prospective study in consecutive patients undergoing 
FFR for clinical indications using proprietary software to calculate iFR®. We 
measured Pd/Pa, iFR®, FFR and hyperemic iFR (HiFR). Diagnostic accuracy vs 
FFR <0.80 was calculated using binary cut-off values of ≤0.90 for iFR® and 
≤0.92 for Pd/Pa and adenosine zones for iFR® of 0.86-0.93 and Pd/Pa of 0.87-
0.94 in the hybrid strategy.  
197 patients with 257 stenoses (mean DS 48%) were studied. Using binary cut-
offs diagnostic accuracy was similar for iFR and resting Pd/Pa with 
misclassification rates of 21% vs 20.2%, p= 0.85. In the hybrid analysis, 54% of 
iFR cases and 53% of Pd/Pa cases were outside the adenosine zone and rates 
of misclassification were 9.4% vs 11.9%, p=0.55.  
Conclusions: Binary cut-off values for iFR and Pd/Pa result in misclassification 
of 1 in 5 lesions. Using a hybrid strategy approximately half of the patients do 
not receive adenosine but 1 in 10 lesions are still misclassified. The use of non-
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hyperaemic indices of stenosis severity cannot be recommended for decision 
making in the cath lab.  
Clinical Trial Registration: NCT02377310 
https://clinicaltrials.gov/ct2/show/NCT02377310 
Keywords  
FFR 
iFR 
Coronary Physiology 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 5 
 
Introduction 
Fractional flow reserve (FFR) is the ratio of distal coronary pressure to aortic 
pressure (Pd/Pa) across a stenosis measured during maximal hyperemia, most 
commonly achieved by the intra-coronary or intra-venous administration of 
adenosine. Multiple studies have demonstrated that FFR guided 
revascularization improves clinical outcomes compared to angiographic 
guidance alone (1-3). This has resulted in a Class 1 recommendation from the 
ESC and a Class 2a recommendation from the ACC/AHA for the use of FFR (4, 
5). Despite this, there has only been limited adoption of FFR into routine clinical 
practice (6). Some observers have suggested that this is due to the need to 
induce maximal hyperemia to measure FFR and have consequently studied and 
promoted the use of resting (non-hyperemic) indices of stenosis severity 
including Pd/Pa (7,8)  and the instantaneous wave free ratio (iFR®) which 
through utilization of a patented algorithm measures the trans-stenotic pressure 
ratio in the so called “wave free period” of diastole (9). Initially it was proposed 
that iFR® could be utilized for decision making using a dichotomous cut-off value 
in a similar fashion to FFR. In the ADVISE registry (n=339 stenoses) an iFR® 
value of ≤0.89 provided 80% agreement with the widely used FFR cut-off value 
of ≤0.80 (10).  
At present, there are several ongoing clinical studies utilizing iFR for decision 
making in the catheter laboratory. In the DEFINE FLAIR (NCT02053038) and 
iFR SWEDEHEART (NCT02166736) trials patients are randomized to iFR (no 
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adenosine) or FFR-guided management using a binary cut-off for iFR of <0.90 
and the usual FFR cut-off value of ≤0.80. In the SYNTAX II study 
(NCT02015832), in an effort to improve agreement with FFR, a hybrid decision 
making strategy is employed in which if the iFR is between 0.86 to 0.93, 
adenosine is administered and Percutaneous Coronary Intervention (PCI) 
performed if the FFR is ≤0.80. If the iFR is < 0.86, PCI is performed anyway 
without any FFR measurement and if the iFR is > 0.93, no PCI is performed. 
Compared to standard of care FFR guided decision-making, this study sought to 
quantify the rates of inappropriate and/or incomplete revascularization with 
strategies utilising resting indices of stenosis severity. Specifically, we compared 
the levels of agreement between iFR and Pd/Pa based algorithms using the 
previously described optimal cut-off values of ≤0.90 for iFR® and ≤0.92 for 
Pd/Pa (binary strategy) and the previously described adenosine zones for iFR® 
of 0.86-0.93 and Pd/Pa of 0.87-0.94. We hypothesized that rates of diagnostic 
accuracy would be similar with both resting indices and both strategies.  
 
 
 
Methods 
 
This is a single center prospective study in near consecutive patients 
undergoing pressure wire studies for standard indications. The project was 
based on approval from the UK National Research Ethics Service, and 
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management approval in the Golden Jubilee National Hospital, Glasgow. All 
patients were required to provide written informed consent for their data to be 
recorded and analyzed. Patients aged 18 to 90 years old with angiographically 
intermediate coronary stenoses in which FFR measurement was clinically 
indicated were eligible to be included. Standard exclusion criteria for pressure 
wire studies applied and included the following; severe calcific coronary disease, 
severe tortuosity rendering pressure wire studies difficult or impossible, recent 
myocardial infarction within the previous 72 hours, ongoing unstable chest pain, 
known intolerance of adenosine or severe asthma. 
Prior to being admitted to the cardiac catheterization laboratory patients had a 
large bore cannula inserted in an antecubital fossa vein for the administration of 
intravenous (IV) adenosine (140 mcg/kg/min) as per standard institutional 
practice. Following diagnostic angiography, the Volcano Prestige® or Verrata® 
Wire (Volcano Corporation, Rancho Cordova, CA) was inserted into the guide 
catheter, calibrated and passed to the distal third of the coronary artery beyond 
the lesion of interest. Once in position and following the administration of intra-
coronary isosorbide dinitrate (200mcg), resting Pd/Pa was recorded followed by 
iFR®. Then IV adenosine was administered until conditions of stable maximal 
hyperemia had been established. Both minimum and steady state FFR were 
noted and finally HiFR was measured again in duplicate. Care was taken to 
ensure FFR was recorded during stable haemodynamic conditions with a 
consistent FFR reading for ≥ 5 beats denoting steady state values. The 
adenosine was then stopped and the wire withdrawn to the guide catheter to 
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check for “pressure drift”. If pressure drift of > 0.03 was detected the data 
acquisition was repeated. The data was stored on the Volcano s5® Console 
HDD with intermittent anonymized data backup to an encrypted hard disk drive 
for archiving and external core lab analysis. The results were recorded on a 
standardized case report form by the operating cardiologist and further patient 
demographics and risk factor data were extracted from the online electronic 
patient record and tabulated for analysis. All vessels were analyzed for QCA 
data by an interventional cardiologist (BH and PM) blinded to the pressure wire 
data on a Centricity CA 1000 Cardiac Review 1.0 workstation. Syntax scores 
were calculated before and after PCI using version 2.11 of the online Syntax 
Score Calculator. The well validated Alberta Provincial Project for Outcome 
Assessment in Coronary Heart Disease (APPROACH) (11) score was used to 
describe the percentage of myocardium at risk based on visual and QCA 
estimation of stenosis ≥50%. Multiple QCA parameters were analyzed to 
explore variation in rates of misclassification versus FFR ≤0.80.  
Statistics 
The statistical analysis for the main study hypothesis was performed by a 
biostatistician (JM) who was independent of the clinical research team. The null 
hypothesis was that there would be no difference in the level of agreement with 
FFR between iFR and resting Pd/Pa. To ensure that the limits of a two-sided 
95% confidence interval would exclude a difference in agreement of at least 5% 
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with 80% power we determined that 254 vessels would have to be studied. Data 
was anonymized, transferred and analysed according to the predetermined 
statistical plan without any further consultation between the chief investigator 
and statistician. Pearson Chi square tests, Fisher’s exact test and the McNemar 
test were performed where appropriate to assess for statistical significance. We 
analyzed the data and produced summary statistics using SPSS statistics 
package Version 21.0. Armonk, NY: IBM Corp. We compared iFR®, HiFR and 
Pd/Pa with FFR using correlation coefficients and generated Receiver-Operating 
Characteristic (ROC) curves to determine the discriminatory power of iFR® and 
Pd/Pa outside the pre-specified adenosine ranges for Pd/Pa of 0.87-0.94 
inclusive and for iFR of 0.86-0.93 inclusive as well as for the binary cut-off 
values of ≤0.92 for Pd/Pa and ≤0.90 for iFR®. ROC curves were compared with 
DeLong's test (12) using the pROC package (13) in R (http://www.R-
project.org/). We calculated rates of inappropriate and incomplete 
revascularization associated with each of the treatment strategies involving 
Pd/Pa and iFR® and compared these to an FFR only guided strategy.  Segment 
location and QCA parameters were analyzed to determine whether they affected 
the diagnostic accuracy of the non-hyperemic indices. The primary endpoint was 
the level of agreement of iFR® versus Pd/Pa using binary cut-off values in 
reference to FFR ≤0.80.  
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Results 
Study Population We studied 197 patients with 257 moderate coronary 
stenoses. The clinical characteristics of these patients are shown in Table 1. 
The vessels studied had mean (SD) diameter stenosis of 48 (13)% and a mean 
(SD) area stenosis of 71 (14)%. Mean (SD) lesion length was 16.4 (10.3) mm. 
The mean FFR in our study was 0.81 +/- 0.09 (Figure 1) as compared to a mean 
of 0.83 +/- 0.11 in ADVISE 2 (14). The mean (SD) APPROACH score was 21.6 
(16.6)%. The resting pressure measurements were recorded before the FFR 
measurements, therefore the operator was unaware of the FFR results at the 
time of the iFR® and Pd/Pa recordings. Of the 257 lesions, 84 (33%) were 
classified as complex on the basis of exhibiting two or more of the following: 
thrombus, ulceration, irregularity, moderate to severe calcification or bifurcation 
location. 
Agreement with FFR using Binary Cut-Off Values for iFR and Pd/Pa 
 
Correlation coefficients (Spearman's rho values) for Pd/Pa vs FFR and iFR® vs 
FFR were similar at 0.752 and 0.733 respectively (Table 2). Using the 
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RESOLVE study (15) cut-off values for iFR® at ≤0.90 and Pd/Pa ≤0.92 (Figure 2) 
the level of misclassification compared to FFR ≤0.80 was similar: 21% versus 
20.2% p= 0.85 (Table 3). The area under the ROC curve for iFR® and Pd/Pa 
were 0.853 vs 0.858, p=0.79 (Figure 3). As previously reported the relationship 
between Pd/Pa and iFR® was highly linear: iFR® = 1.502 * Pd/Pa - 0.503 
(r=0.98). 
 
Agreement with FFR using Hybrid Algorithms (iFR-FFR and Pd/Pa-FFR)  
 
In the hybrid analysis, 54% of cases were outside the pre-specified adenosine 
zone of 0.86-0.93 for iFR® and 53% of cases were out with pre-specified 
adenosine zone of 0.87-0.94 for Pd/Pa. In all vessels the rates of 
misclassification were 9.4% for iFR and 11.9% for Pd/Pa, p=0.55 (Table 4). 
Sensitivities and specificities (%) are shown in table 5 according to index and 
cut-off value. 
Levels of Incomplete Revascularization and Inappropriate PCI 
Using binary cut-off values (versus the gold standard of FFR≤0.80 for ischemia), 
the numbers of inappropriate PCI were 26/257(10%) for iFR and 25/257(9.7%) 
for Pd/Pa, p=1.00 and the numbers of incomplete revascularization were 
28/257(11%) for iFR and 27/257(10.5%) for Pd/Pa, p=1.00. Using the hybrid 
strategy, the rates of inappropriate PCI were 2/139(1.4%) for iFR and 0/135(0%) 
for Pd/Pa, p=0.16 and the rates of incomplete revascularization were 
11/139(8%) for iFR and 16/135(11.9%) for Pd/Pa, p=0.10.  
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Proximal vs non-proximal coronary segments 
We analysed iFR and Pd/Pa based decision making strategies in stenoses in 
proximal coronary vessels (Syntax segments 1, 5, 6 and 11) compared to all 
other lesions. 
Binary strategy: Using iFR® the levels of misclassification were 27.7% in 
proximal stenoses vs 15.2% in non-proximal stenoses, p=0.014 (Table 6). Using 
Pd/Pa the levels of misclassification were 24.4% in proximal stenoses vs 16.7% 
in non-proximal stenoses, p=0.12. 
Hybrid strategy: Using iFR the levels of misclassification were 8.3% in proximal 
stenoses vs 10.1% in non-proximal stenoses, p=0.77. Using Pd/Pa the levels of 
misclassification were 14.1% in proximal stenoses vs 9.9% in non-proximal 
stenoses, p=0.60. (Table 7).  
 
 
Levels of Agreement Excluding vessels with Grey Zone FFR Values 
When all vessels with an FFR 0.75-0.80 are excluded the rates of 
misclassification were 16.8% for iFR and 15.3% for Pd/Pa (p=0.66) using the 
binary cut-off values as per the primary study analysis. When using the hybrid 
strategy cut-off values the rates of misclassification were 3.4% for iFR and 4.2% 
for Pd/Pa, p=1.00. 
 
Discussion 
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The RESOLVE study was the first multi-centre, core-lab adjudicated 
independent comparative analysis of iFR and resting Pd/Pa using the 
proprietary Volcano Corporation HarvestTM software to calculate iFR® (n=1768 
patients). RESOLVE confirmed 80% agreement between iFR® and FFR with an 
optimal cut-off value for iFR® of 0.90 (15). The level of agreement between 
Pd/Pa and FFR was 81% with an optimal cut off value of 0.92, confirming the 
results of the previously published VERIFY study (16) and the subsequent 
ADVISE II study (14). Although first described as an 'adenosine-independent 
index', in fact, the value of iFR® falls significantly with adenosine as first 
demonstrated in the VERIFY study, confirming that myocardial resistance during 
the wave free period is neither minimal nor equivalent to mean whole cardiac 
cycle resistance during hyperemia (16).  
Our results indicate that there is no diagnostic advantage to utilizing a vendor-
specific iFR® guided revascularization strategy beyond that which is already 
available on all pressure sensing guidewire/microcatheter systems utilizing 
Pd/Pa. The results also indicate that operators who routinely utilize resting 
indices for decision making can anticipate a 1 in 5 level of misclassification 
compared to FFR (Figure 4) with the binary cut-off strategy and a 1 in 10 level of 
misclassification compared to FFR utilizing a hybrid strategy regardless of 
whether Pd/Pa or iFR® is used, again in line with previous published studies. As 
a result of this we cannot recommend the use of resting indices in clinical 
practice at present. Beyond that, the multicenter CONTRAST Study which 
involved 763 subjects enrolled in 12 international centres, has shown that simple 
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contrast hyperemia has a superior diagnostic ability than resting indices and 
therefore institutions with limited access to hyperemic agents could consider 
contrast hyperemia as a superior alternative (17). Notably, and in contrast to 
Pd/Pa, iFR® was associated with a higher rate of misclassification in proximal 
vs. non-proximal lesions. This observation relates to the fact that proximal 
stenoses generally subtend larger myocardial territories and manifest higher 
increases in coronary blood flow when vasodilators are administered (18). 
Accordingly a small “negative” resting gradient may develop into a clinically 
significant FFR value during hyperaemia (Figure 4). At least in our estimation, a 
decision making strategy based on resting pressures represents a sub-optimal 
and currently non-evidence based approach. There are two ongoing non-
inferiority studies comparing the clinical outcomes of patients undergoing iFR vs 
FFR guided PCI using binary cut-off values and therefore no hyperaemia at all 
in the patients allocated to iFR guidance (19). Although these studies will 
provide important data on clinical outcomes using iFR guidance a potentially 
more appropriate study design to test would require randomization to 
revascularisation or not of patients in whom iFR and FFR provide divergent 
treatment decisions.  
Strengths and Weaknesses of this Study 
Although we conducted a single center study, the results are nonetheless 
clinically relevant. Our data were obtained during routine clinical care, represent 
a contemporary, real world experience of prospectively collected data and were 
analyzed using proprietary software. None of the recordings were excluded. The 
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mean FFR  value in our population was very close to the cut-off value of 0.80 
used for decision making confirming that FFR assessment was appropriately 
used and that the comparative analyses between resting and hyperemic indices 
conducted were not skewed by a preponderance of extreme values. 
 
The global adoption of coronary physiology guided management is increasing 
with up to 30% usage in the U.S.A. following the recent publication of  
appropriate use criteria (20). As uptake increases, so education and training 
becomes increasingly important, especially for clinicians who may be less 
familiar with the differential accuracy of resting and hyperaemic indices of 
stenosis severity. The hybrid decision making strategies may in fact add to the 
complexity of interpretation of results and in doing so paradoxically increase 
operator reluctance to utilise pressure wire technology. A further concern with 
the hybrid strategy is that the value of FFR will remain unknown up to half of the 
patients, precluding any clinically relevant assessment of the recently 
demonstrated relationship between FFR and prognosis which may be a 
questionable trade off for many cardiologists (21). 
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Figure Legends 
Figure 1 Frequency Histogram of vessel number ( where n=257) versus Steady 
state FFR value (Steady state FFR is conventional fractional flow reserve at the 
most stable point in hyperemia as observed by the operating cardiologist) with a 
y-axis reference line at the mean FFR value of 0.812. 
 
 
Figure 2. Scatterplot demonstrating the relationship between FFR and iFR with 
a 0.90 cutoff for iFR (y-axis reference line) and 0.80 cut-off for FFR (x-axis 
reference line). (a)= false negative iFRs (b)= True negative iFRs (c)= True 
positive iFRs (d)= False positive iFRs. 
 
Figure 3. Scatterplot demonstrating the relationship between Pd/Pa and FFR 
with a 0.92 cutoff for Pd/Pa (y-axis reference line) and 0.80 cut-off for FFR (x-
axis reference line). (a)= false negative Pd/Pas (b)= True negative Pd/Pas (c)= 
True positive Pd/Pas (d)= False positive Pd/Pas.  
 
 
Figure 4. Receiver Operator Characteristic Curves demonstrating diagnostic 
accuracy of iFR, Pd/Pa and HiFR in reference to FFR ≤0.80.                                                     
Delong’s test p-values for 2 correlated ROC curves: iFR vs Pd/Pa: 0.793 HiFR 
vs iFR: 0.0001, HiFR vs Pd/Pa : 0.0003  
 
Figure 5. 57 year old man who underwent coronary physiology 16 days post 
NSTEMI with troponin I of 0.2  ug/L. Moderate mid LAD disease with a QCA 
Diameter stenosis 50.25% with area stenosis of 75.25% . Pd/Pa= 0.95, 
iFR=0.94, FFR=0.80.  Managed medically with no recurrence of angina reported 
at 2 years post MI. 
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Table 1 Clinical characteristics of study population (n=197) 
 
n %  
Male 136  69  
Family History CAD 122 61.9  
Diabetic 31 15.7  
Hypertension 123 62.4  
Smoking 48 24.4  
Hyperlipidemia 133 67.5  
Previous MI 73 37.1  
Previous PCI 55 
 
27.9 
 
    
Vessels (n=257) 
 
  
LAD 148 57.6  
RCA 45 17.5  
LCX 37 14.4  
OM 12 4.7  
LMS 
 
9 3.5  
Diagonal 6 2.3  
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Clinical presentation N=257 %  
Stable Angina 129 50.1  
NSTEMI 79 30.1  
Unstable Angina 18 7.0  
Atypical Chest Pain 13 5.1  
Convalescent STEMI 8 3.0  
CCF 5 2.0  
Arrhythmia 3 1.2  
Pre-Valve Surgery 2 1.0  
 
 
Convalescent STEMI Patients (n=5) were as follows;  
1. Non culprit LAD FFR within 24 hours of spontaneously resolved transient 
inferior ST elevation due to RCA culprit. 
2. FFR of LAD and LPDA in a patient with a >48 hours late presenting Q 
wave MI due to an OM Culprit 
3. FFR of LCX and RCA in a patient 19 days post late anterior STEMI 
4. FFR LAD culprit vessel 2 months post successful thrombolysis with 
moderate residual plaque  
5. FFR LCX and LAD in a patient with a late inferior STEMI > 4 days due to 
an RCA culprit.  
 
 
CAD: coronary artery disease; MI: myocardial Infarction; PCI: Percutaneous 
coronary intervention; LAD: left anterior descending artery; LCx: left 
circumflex artery; RCA=Right coronary artery; OM=Obtuse marginal artery 
LMS= Left main stem artery; NSTEMI= Non ST elevation myocardial 
infarction; STEMI= ST elevation myocardial infarction; CCF= Congestive 
cardiac failure; LPDA= Left posterior descending artery 
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Table 2. Correlation coefficients between resting and hyperaemic indices 
 
 Pd/Pa iFR 1 
Minimal 
FFR 
Steady State 
FFR Value 
Spearman's 
rho 
Pd/Pa Correlation 
Coefficient 
1.000 .889 .743 .752 
 N/A (P=0.001) (P=0.001) (P=0.001) 
     
iFR 
 
Correlation 
Coefficient .889 1.000 .720 .733 
 (P=0.001) N/A (P=0.001) (P=0.001) 
     
Minimal FFR  Correlation 
Coefficient .743 .720 1.000 .981 
 (P=0.001) (P=0.001) N/A (P=0.001) 
     
Steady State 
FFR Value  
Correlation 
Coefficient 
.752 .733 .981 1.000 
 (P=0.001) (P=0.001) (P=0.001) N/A 
     
H-iFR 1 Correlation 
Coefficient 
.697 .727 .904 .913 
 (P=0.001) (P=0.001) (P=0.001) (P=0.001) 
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Pd/Pa is resting whole cycle mean pressure ratio, iFR is the instantaneous wave-free 
ratio, Minimal FFR is conventional fractional flow reserve at the minimal observed ratio, 
Steady state FFR is conventional fractional flow reserve at the most stable point in 
hyperemia as observed by the operating cardiologist and Hyperemic iFR (H-iFR) is iFR 
analysis performed during steady state hyperemic conditions. NA= Not Applicable. P 
values indicated in parentheses below correlation coefficients. 
 
 
 
 
 
 
 
Table 3. Sensitivity Analyses for iFR and Pd/Pa Using Defined Binary Cut-
Off Compared with FFR. 
 
 
 Value FFR≤0.8 FFR>0.8 Misclassification (%) 
iFR 
≤0.9 81 26 
21 
≥0.9 28 122 
Pd/Pa 
≤0.92 82 25 
20.2 
>0.92 27 123 
 
 
iFR vs Pd/Pa – McNemar's chi-squared = 0.03, df = 1, p-value = 0.85 
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Table 4. Sensitivity Analyses for iFR and Pd/Pa Using Defined adenosine 
zones Compared with FFR ≤0.80.   
 
 
 
 
 
 
 
 
 
 
 
McNemar's chi-squared* = 0.3636, df = 1, p-value = 0.5465 
  *Lesions out with the iFR adenosine zone (0.86-0.93) 54.1% of vessels. 
  **Lesions out with the Pd/Pa adenosine zone (0.87-0.94) 52.5% of vessels. 
 
 
 
 Table 5. demonstrating the sensitivity, specificity, positive predictive value and negative predictive value (%) according to both binary and hybrid cut-offs for iFR and Pd/Pa. 
 
 Parameter and cut-off Sensitivity (%) Specificity (%) Positive Predictive Value (%) Negative Predictive Value (%) 
iFR ≤0.90 Binary Cut-off 74.3 82.4 75.7 81.3 
Pd/Pa ≤0.92 Binary cut-off 75.2 83.1 76.6 82 iFR 0.86-0.93 Adenosine Zone Hybrid Analysis 
89.9 98.6 95.9 87.8 
Pd/Pa 0.87-0.94 Adenosine Zone Hybrid Analysis 
85.3 100 100 85.1 
 
 
 
 
 
Modality Value Number (n) 
Concordant 
(n) 
Discordant 
(n) 
Misclassification 
(%) 
iFR* <0.86 49 47 2 9.4 >0.93 90 79 11 
Pd/Pa** <0.87 27 27 0 11.9 >0.94 108 92 16 
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Table 6. Sensitivity Analyses for iFR in Proximal vs Distal segments Using 
≤0.9 Cut-Off Compared with FFR . 
 
 
Proximal (Syntax segments 1,11,5,6) vs Distal (Syntax segments ≠ 1,11,5,6) – 
Comparison of 2 proportions: 95% CI=(0.0248, 0.225), Pearson Chi-square test 
of association: p=0.014 Fisher's exact test: p=0.021 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Modality Value FFR≤0.8 FFR>0.8 Misclassification (%) 
iFR proximal  ≤0.9 33 15 27.7 
>0.9 18 53 
iFR distal  ≤0.9 48 11 15.2 
>0.9 10 63 
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Table 7. Sensitivity Analyses for Pd/Pa in Proximal vs Distal segments Using 
≤0.92 Cut-Off Compared with FFR . 
 
 Value FFR ≤ 0.8 
(n) 
 
FFR > 0.8 
(n) 
 
Misclassification 
(%) 
Pd/Pa 
Proximal 
Segments 
 
≤0.92 
 
35 13 
24.4* >0.92 
 
16 55 
Pd/Pa  
Distal 
Segments 
 
≤0.92 
 
47 12 
16.7 >0.92 
 
11 68 
 
Sensitivity Analyses for Pd/Pa in Proximal (Syntax segments 1,11,5,6) vs Distal 
(Syntax segments ≠ 1,11,5,6) 
*: Chi-square test of association: p=0.125. Fisher's exact test: p=0.161 
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